Macrophages promote prosclerotic responses in cultured rat mesangial cells: A mechanism for the initiation of glomerulosclerosis

Journal of the American Society of Nephrology

Volumn 8, Issue 10, 1997, Pages 1525-1536

  Pawluczyk, Izabella Z A ^a   Harris, Kevin P G ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; PLATELET DERIVED GROWTH FACTOR; SURAMIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; GLOMERULOSCLEROSIS; MACROPHAGE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030720866     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Klahr S, Schreiner GF, Ichikawa I: Progression in renal disease. N Engl J Med 318: 1657-1666, 1988
2. Schreiner GF, Cotran RS, Unanue ER: Modulation of Ia and leukocyte common antigen expression in rat glomeruli during the course of glomerulonephritis and aminonucleoside nephrosis. Lab Invest 51: 524-533, 1984
3. Diamond JR, Pesek I, Ruggieri S, Karnovsky MJ: Essential fatty acid deficiency during acute puromycin nephrosis ameliorates late renal injury. Am J Physiol 257: F798-F807, 1989
4. Diamond JR, Pesek-Diamond I: Sublethal X-irradiation during acute puromycin nephrosis prevents late renal injury: Role of macrophages. Am J Physiol 260: F779-F786, 1991
5. Harris KPG, Baker F, Walls J: Early increase in glomerular leukocyte number after a reduction in renal mass: Implication for the pathogenesis of glomerulosclerosis. Clin Sci 85: 27-31, 1993
6. Van Goor H, Van der Horst ML, Fidler V, Grond J: Glomerular macrophage modulation affects mesangial expansion in the rat after renal ablation. Lab Invest 66: 564-571, 1992
7. 1 and fibronectin during nephrosis. Am J Physiol 264: F577-F584, 1993
8. Ding G, Van Goor H, Frye J, Diamond JR: Transforming growth factor β expression in macrophages during hypercholesterolaemic states. Am J Physiol 267: F937-F943, 1994
9. Okuda S, Languino LR, Ruoslahti E, Border WA: Elevated expression of transforming growth factor β and proteoglycan production in experimental glomerulonephritis: Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86: 453-462, 1990
10. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulosclerosis by anti-serum against transforming growth factor β. Nature (Lond) 346: 371-374, 1990
11. Isaka Y, Fujiwara Y, Veda N, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor β or platelet-derived growth factor gene in the rat kidney. J Clin Invest 92: 2597-2601, 1993
12. Foidart JB, Dechenne CA, Mahieu P, Creutz CE, De Mey J: Tissue culture of normal glomeruli: Isolation and morphological characterisation of two homogeneous cell lines. Invest Cell Pathol 2: 15-26, 1979
13. Kohan DE, Schreiner GF: Interleukin-1 modulation of renal epithelial glucose and amino acid transport. Am J Physiol 254: F879-F886, 1988
14. Coffey RJ, Leof EB, Shipley GD, Moses HL: Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J Cell Physiol 132: 143-148, 1987
15. Betholtz C, Johnsson A, Heldin CH, Westermark B: Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin. Proc Natl Acad Sci USA 83: 6440-6444, 1986
16. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurements with the Folin reagent. J Biol Chem 193: 265-275, 1951
17. Schwarzbauer JE, Tamkun WJ, Lemischka IR, Hynes RO: Three different fibronectin mRNAs arise by alternate splicing within the coding region. Cell 35: 421-431, 1983
18. Kurkinen M, Condon MR, Blumberg B, Barlow DP, Quinones S, Saus J, Pihlajaniemi T: Extensive homology between the carboxy-terminal peptides of mouse α1(IV) and α2(IV) collagen. J Biol Chem 262: 8496-8499, 1987
19. Barlow DP, Green NM, Kurkinen M, Hogan BLM: Sequencing of laminin B chain cDNAs reveals C-terminal regions of coiled-coil alpha helix. EMBO J 3: 2355-2362, 1984
20. Millan F, Denhez F, Kondaiah P, Ackurst R: The embryonic gene expression patterns of TGFβ1, 2 and 3 suggest differential developmental function in vivo. Development 111: 131-144, 1991
21. Mercola M, Wang C, Kelly J, Brownlee C, Jackson-Grusby L, Stiles C, Bowen-Pope DF: Selective expression of PDGF A and its receptor during early mouse embryogenesis. Dev Biol 138: 114-122, 1990
22. Nicholson R, Murphy G, Breathnach R: Human and rat malignant tumour associated mRNAs encode a stromelysin-like metalloproteinase. Biochemistry 28: 5195-5203, 1989
23. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6: 121-125, 1990
24. Alitalo K, Hovi T, Vaheri A: Fibronectin is produced by human macrophages. J Exp Med 151: 602-613, 1980
25. Werb Z, Chin JR: Biosynthetic radiolabeling of cellular and secreted proteins of mononuclear phagocytes. In: Methods for Studying Mononuclear Phagocytes, edited by Adams DO, Edelson PJ, Koren H, New York, Academic, 1981, pp 861-872
26. Dubois CH, Goffinet G, Foidart JB, Dechene CA, Foidart JM, Mahieu PR: Evidence for a particular binding capacity of rat peritoneal macrophages to rat glomerular mesangial cells in vitro. Eur J Clin Invest 12: 239-246, 1982
27. Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA: Pathogenesis of interstitial fibrosis in chronic purine amino-nucleoside nephrosis. Kidney Int 40: 1020-1031, 1991
28. Ooi YM, Weiss MA, Hsu A, Ooi BS: Mechanisms of suppression of mouse mesangial cell proliferation by macrophage supernatants. J Immunol 130: 1790-1795, 1983
29. Lovett DH, Ryan JL, Sterzel RB: Stimulation of rat mesangial cell proliferation by macrophage interleukin-1. J Immunol 130: 1790-1795, 1983
30. Mattana J, Singhal PC: Macrophage Fc receptor activity modulates mesangial cell proliferation and matrix synthesis. Am J Physiol 266: F568-F575, 1994
31. Singhal PC, Mattana J, Garg P, Arya M, Shan Z, Gibbons N, Franki N: Morphine- induced macrophage activity modulates mesangial cell proliferation and matrix synthesis. Kidney Int 49: 94-102, 1996
32. Weissgarten J, Berman S, Averbukh Z, Cohn M, Golik A, Cohen N, Modai D: Renal mononuclear cells secrete a factor triggering mesangial cell proliferation. Nephrol Dial Transplant 8: 118-121, 1993
33. Mattana J, Singhal PC: Macrophage supernatants have both stimulatory and suppressive effects on mesangial cell proliferation. J Cell Physiol 154: 289-293, 1993
34. Striker LJ, Doi T, Elliot S, Striker GE: The contribution of glomerular mesangial cells to progressive glomerulosclerosis. Semin Nephrol 9: 318-328, 1989
35. Eng E, Floege J, Young BA, Couser WG, Johnson RJ: Does extracellular matrix expansion in glomerular disease require mesangial cell proliferation? Kidney Int 45(Suppl 45): 44-47, 1994
36. Groggel GC, Hughes ML: Heparan sulphate stimulates extracellular matrix protein synthesis by mesangial cells in culture. Nephron 71: 197-202, 1995
37. Zhu L, Herrera GA, Murphy-Ullrich JE, Huang Z-Q, Sanders PW: Pathogenesis of glomerulosclerosis in light chain deposition disease: Role for transforming growth factor β. Am J Pathol 147: 375-385, 1995
38. Ayo SH, Radnik RA, Garoni J, Glass FW II, Kreisberg JI: High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 136: 1339-1348, 1990
39. Bruggeman LA, Pelicoro JA, Horigan EA, Klotman PE: Thromboxane and prostacyclin differentially regulate murine extracellular matrix gene expression. Kidney Int 43: 1219-1225, 1993
40. Wagner C, Braunger M, Beer M, Rother K, Hansch GM: Induction of matrix protein synthesis in human glomerular mesangial cell by the terminal complement complex. Exp Nephrol 2: 51-56, 1994
41. Rossi P, Karsenty G, Roberts AB, Roche NS, Sporn MB, de Crombrugghe B: A nuclear factor 1 binding site mediates the transcriptional activation of a type 1 collagen promoter by transforming growth factor β. Cell 52: 405-414, 1988
42. Dean DC, Newby RF, Bourgeois S: Regulation of fibronectin biosynthesis by dexamethasone, transforming growth factor β and cAMP in human cell lines. J Cell Biol 106: 2159-2170, 1988
43. Roberts AB, Flanders KC, Kondaiah P, Thompson NL, Obberghen-Schilling E, Wakefield LM, Rossi P, de Crombrugghe DH, Heine U, Sporn MB: Transforming growth factor β: Biochemistry and roles in embryogenesis, tissue repair and remodelling and carcinogenesis. Recent Prog Horm Res 44: 157-197, 1988
44. Kaname S, Vehida S, Ogata E, Kurokawa K: Autocrine secretion of transforming growth factor β in cultured rat mesangial cells. Kidney Int 42: 1319-1327, 1992
45. Border WA, Ruoslahti E: Transforming growth factor β: The dark side of tissue repair. J Clin Invest 90: 1-7, 1992
46. Border WA, Okuda S, Languino LR, Ruoslahti E: Transforming growth factor β regulates production of proteoglycans by mesangial cells. Kidney Int 37: 689-695, 1990
47. Hibbs JB Jr, Taintor RR, Chapman HA Jr, Weinberg JB: Macrophage tumour killing: Influence of local environment. Science 197: 279-282, 1977
48. Chapman HA Jr, Hibbs JB Jr: Modulation of macrophage tumoricidal capability by components of normal serum: A central role for lipid. Science 197: 282-285, 1977
49. Doherty DE, Haslett C, Tonnesen MG, Henson PM: Human monocyte adherence: A primary effect of chemotactic factor on the monocyte to stimulate adherence to human endothelium. J Immunol 138: 1762-1771, 1987
50. Haskill S, Johnson C, Eierman D, Becker S, Warren K: Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes. J Immunol 140: 1690-1694, 1988